Clinical trial participation and outcome for patients with glioblastoma: Multivariate analysis from a comprehensive dataset
Authors:
- Kathryn M. FieldKFKathryn M. Field
- Katharine J. DrummondKDKatharine J. Drummond
- Merve YilmazMYMerve Yilmaz
- Mark TaceyMTMark Tacey
- Daniel CompstonDCDaniel Compston
- Peter GibbsPGPeter Gibbs
- Mark A. RosenthalMRMark A. Rosenthal
- 1 June 2013
- journal article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 20 (6) , 783-789
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Gender, Race, and Socioeconomic Status Affects Outcomes After Lung Cancer Resections in the United StatesThe Annals of Thoracic Surgery, 2011
- An Interaction of Race and Ethnicity With Socioeconomic Status in Rectal Cancer OutcomesAnnals of Surgery, 2011
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Social inequality and incidence of and survival from tumours of the central nervous system in a population-based study in Denmark, 1994–2003European Journal of Cancer, 2008
- Area disadvantage, individual socio-economic position, and premature cancer mortality in Australia 1998 to 2000: a multilevel analysisCancer Causes & Control, 2007
- Effects of socioeconomic and geographic variations on survival for adult glioma in England and WalesSurgical Neurology, 2006
- The benefit of participating to clinical researchBreast Cancer Research and Treatment, 2005
- Systematic review to determine whether participation in a trial influences outcomeBMJ, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Are randomized clinical trials good for us (in the short term)? Evidence for a “trial effect”Journal of Clinical Epidemiology, 2001